DNMT3B对人脐带间质干细胞成骨分化能力的影响

《中国期刊全文数据库》收录期刊
《中国核心期刊（遴选）数据库》收录期刊
《中文科技期刊数据库》收录期刊

外科研究与新技术 ›› 2012, Vol. 1 ›› Issue (2): 103-107.

• 论著 • 上一篇下一篇

DNMT3B对人脐带间质干细胞成骨分化能力的影响

吴周睿, 胡笑, 徐委, 孙晓晴, 管晓菲, 程黎明

同济大学附属同济医院脊柱外科,上海 200065

出版日期:2012-12-28 发布日期:2012-02-25
通讯作者: 程黎明(1968-),男,外科学博士、教授、主任医师、博士生导师.主攻方向:脊柱脊髓损伤修复与再生研究,脊柱脊髓退行性疾病研究.E-mail: chlm.d@163.com
作者简介:吴周睿(1985-), 男, 湖北人, 博士研究生, 脊柱外科损伤.
基金资助:
国家国际科技合作计划资助项目(2011DFB30010)

DNMT3B regulates osteogenesis of Human Umbilical Mesenchymal Stem Cells

Wu Zhou-Rui, Hu Xiao, Xu Wei, Sun Xiao-Qing, Guan Xiao-Fei, Cheng Li-Ming

Department of Spinal Surgery, Tongji Hospital, Shanghai 200065,China

Online:2012-12-28 Published:2012-02-25

摘要/Abstract

摘要： 目的研究DNA甲基化转移酶3B(DNA methyltransferase 3B, DNMT3B)调控人脐带间质干细胞骨生成的作用。方法利用RNA干扰法获得两株DNMT3B基因低表达的人脐带间质干细胞(Human Umbilical Mesenchymal Stem Cells, hUMSCs)。在使用qPCR和免疫组织化学法确定DNMT3B表达缺失后, 对hUMSCs进行骨生成定向诱导分化。并利用免疫组织化学法和茜素红染色评价突变型和野生型hUMSCs成骨能力差异。结果由RNA干扰获得的两株突变型hUMSCs中两株突变型中DNMT3B表达量分别下降至野生型hUMSCs的12.67±0.45%和35.60±0.76%(P<0.05)。而在DNMT3B突变型hUMSCs中间质干细胞标记物CD73和CD90基因mRNA的表达水平也分别下降(P<0.05)。CD73水平分别是野生型细胞的15.83±0.44%和16.60±0.37% (P<0.05);CD90的水平分别是野生型细胞的35.23±0.30%和58.64±0.71% (P<0.05)。在骨生成过程中, 免疫组化染色后镜下比较显示DNMT3B突变型的细胞表达Osteocalcin较正常细胞低, qPCR结果表明RUNX2, IBSP 和 ALPL基因的mRNA表达量水平较正常细胞均明显下降(P<0.01), 其中shD3B-1和shD3B-2的RUNX2基因表达水平分别为正常细胞的55.09±0.53%和53.77±0.47% (P<0.01);IBSP基因表达水平分别为正常细胞的53.21±0.81%和41.75±0.44% (P<0.01);ALPL基因表达水平分别为正常细胞的15.55±0.10%和17.86±24% (P<0.01)。同时茜素红染色检测也显示其成骨后细胞成骨功能减弱。结论 DNMT3B突变或缺失会导致hUMSCs骨生成能力下降。

关键词: 骨生成, 间质干细胞, DNA甲基化转移酶3B, DNA甲基化

Abstract: Objective To elucidate the roles of DNMT3B in the osteogenesis of hUMSCs.Methods Knockdown DNMT3B in hUMSCs was gained via RNA interference technology.After confirming the decrease of DNMT3B in mutant hUMSCs by immunostaining and qPCR, osteogenesis differentiation was carried out.To identify the phenotype of osteogenesis in both bone formation ability and function of bone,immunostaining,qPCR and functional test was preformed,compared to widetype hUMSCs.Results The mutant hUMSCs showed lower DNMT3B expression level by qPCR.Compared to widetype cells,the DNMT3B expression level were 12.67±0.45% and 35.60±0.76%in two mutant hUMSCs (P<0.05).Furthermore,the expression level of CD73 and CD90 that were two mesenchymal specific markers were 15.83±0.44% and 16.60±0.37% of widetype hUMSCs (P<0.05).Immunostaining showed Osteocalcin positive cell was significant less in DNMT3B mutant cells.qPCR demonstrated that RUNX2,IBSP and ALPL mRNA level were decreased in mutant cells (P<0.01).Moreover,alizarin red staining performed that functional impairment lacking of DNMT3B in hUMSCs.Conclusion The osteogenesis differentiation of hUMSCs is impaired in the absence of DNMT3B.

Key words: Osteogenesis, Mesenchymal stem cells, DNA methyltransferase 3B, DNA methylation

中图分类号:

R 681.5+3

吴周睿, 胡笑, 徐委, 孙晓晴, 管晓菲, 程黎明. DNMT3B对人脐带间质干细胞成骨分化能力的影响[J]. 外科研究与新技术, 2012, 1(2): 103-107.

Wu Zhou-Rui, Hu Xiao, Xu Wei, Sun Xiao-Qing, Guan Xiao-Fei, Cheng Li-Ming. DNMT3B regulates osteogenesis of Human Umbilical Mesenchymal Stem Cells[J]. 外科研究与新技术, 2012, 1(2): 103-107.

参考文献

[1] Yagi T,Ito D,Okada Y,et al.Modeling familial Alzheimers disease with induced pluripotent stem cells[J].Hum Mol Genet,2011,20(23):4530-4539.
[2] Wernig M,Zhao JP,Pruszak J,et al.Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease[J].Proc Natl Acad Sci U S A,2008,105(15):5856-5861.
[3] Marchetto MC,Carromeu C,Acab A,et al.A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells[J].Cell,2010,143(4):527-539.
[4] Urbach A,Bar-Nur O,Daley GQ,et al.Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells[J].Cell Stem Cell,2010,6(5):407-411.
[5] Hagleitner MM,Lankester A,Maraschio P,et al.Clinical spectrum of immunodeficiency,centromeric instability and facial dysmorphism (ICF syndrome)[J].J Med Genet,2008,45(2):93-99.
[6] Jiang YL,Rigolet M,Bourchis D,et al.DNMT3B mutations and DNA methylation defect define two types of ICF syndrome[J].Hum Mutat,2005,25(1):56-63.
[7] Wu Z,Huang K,Yu J,et al.Dnmt3a regulates both proliferation and differentiation of mouse neural stem cells.J Neurosci Res,2012,90(10):1883-1891.
[8] Watt F and Molloy PL Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter[J].Genes Dev,1988,2(9):1136-1143.
[9] Lorincz MC,Schubeler D and Groudine M Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation[J].Mol Cell Biol,2001,21(23):7913-7922.
[10] Ehrlich M,Sanchez C,Shao C,et al.ICF,an immunodeficiency syndrome:DNA methyltransferase 3B involvement,chromosome anomalies,and gene dysregulation[J].Autoimmunity,2008,41(4):253-271.

相关文章 1

编辑推荐

Metrics

本文评价